Peripheral somatic nerve function in relation to glucose tolerance in an elderly caucasian population: The Hoorn study

Diabetic Medicine

Volumn 13, Issue 11, 1996, Pages 960-966

  De Neeling, J N D ^a   Beks, P J ^a   Bertelsmann, F W ^b   Heine, R J ^a,b   Bouter, L M ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Ankle tendon reflexes; Caucasians; Glucose tolerance; Population based survey; Quantitative sensory testing; Specific insulin

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; FEMALE; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE FUNCTION; NETHERLANDS; POPULATION RESEARCH; TENDON REFLEX;

AGED; ANKLE JOINT; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISCRIMINATION (PSYCHOLOGY); EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRUCTOSAMINE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; KNEE JOINT; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PERIPHERAL NERVES; REFLEX; SENSORY THRESHOLDS; TOES; VIBRATION;

EID: 0029835439     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199611)13:11<960::AID-DIA268>3.0.CO;2-Z     Document Type: Article

References (32)

1. Brown MJ, Asbury AK. Diabetic neuropathy. Ann Neurol 1984; 15: 2-12.
2. Dyck PJ, Karnes J, O'Brien PC. Diagnosis, staging and classification of diabetic neuropathy and associations with other complications. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D, eds. Diabetic Neuropathy. Philadelphia: Saunders, 1987: 36-44.
3. Boulton AJM. The diabetic foot: neuropathic in aetiology? Diabetic Med 1990; 7: 852-858.
4. Watkins PJ. Natural history of the diabetic neuropathies. QJ Med 1990; 77: 1209-1218.
5. Boulton AJM, Ward JD. Diabetic neuropathies and pain. Clin Endocrinol Metab 1986; 15: 917-931.
6. Ward JD, Fisher DJ, Barnes CG, Jessop JD, Baker RWR. Improvement in nerve condunction following treatment in newly diagnosed diabetics. Lancet 1971; i: 428-431.
7. Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JMM, Clarke BF. Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 1977; 26: 546-550.
8. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-188.
9. Lehtinen JM, Uusitupa M, Siitonen O, Pyörälä K. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989; 38: 1307-1313.
10. Ratzmann KP, Raschke M, Gander I, Schimke E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. J Diab Complications 1991; 5: 1-5.
11. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metabol Rev 1987; 3: 463-524.
12. Fontbonne A, Eschwège E, Cambien F, Richard JL, Ducimetière P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 1989; 32: 300-304.
13. Harris MI. Impaired glucose tolerance in the U.S. population. Diabetes Care 1989; 12: 464-474.
14. Stengård JH, Tuomiletho J, Pekkanen J, Kivinen P, Kaarsalo E, Nissinen A, Karvonen MJ. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: The Finnish cohorts of the The Seven Countries Study. Diabetologia 1992; 35: 760-765.
15. Wingard DL, Barrett-Connor EL, Scheidt-Nave C, McPhillips JB. Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. Diabetes Care 1993; 16: 1022-1025.
16. Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, Wahl PW. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes 1987; 36: 730-739.
17. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990; 131: 633-643.
18. Sosenko JM, Kato M, Soto R, Goldberg RB. Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening. Diabetes Care 1992; 15: 847-852.
19. Wiles PG, Pearce SM, Rice PJS, Mitchell JMO. Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabetic Med 1991; 8: 157-161.
20. Gadia MT, Natori N, Ramos LB, Ayyar DR, Skyler JS, Sosenko JM. Influence of height of quantitative sensory, nerve-conduction, and clinical indices of diabetic peripheral neuropathy. Diabetes Care 1987; 10: 613-616.
21. Victor M, Laureno R. Neurologic complications of alcohol abuse: epidemiologic aspects. In: Schoenberg BS, ed. Advances in Neurology, vol. 19. New York: Raven Press, 1978: 603-617.
22. Mitchell BD, Hawthorne VM, Vinik AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 1990; 13: 434-437.
23. Tegner R. The effect of skin temperature on vibratory sensitivity in polyneuropathy. J Neurol Neurosurg Psychiatry 1985; 48: 176-178.
24. Mooy JM, Grootenhuis PA, De Vries H, Valkenburg HA, Bouter LM, Kostense PJ, Heine RJ. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 1995; 18: 1270-1273.
25. WHO Expert Committee on Diabetes Mellitus. Second Report. WHO Technical Report Series 646. Geneva: World Health Organization, 1980.
26. Beks PJ, Mackaay AJC, De Neeling JND, Vries H de, Heine RJ, Bouter LM. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn Study. Diabetologia 1995; 38: 86-96.
27. De Neeling JND, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM. Sensory thresholds in older adults: reproducibility and reference values. Muscle Nerve 1994; 17: 454-461.
28. Miettinen OS. Theoretical Epidemiology. Principles of Occurrence Research in Medicine. New York: Wiley, 1985: 238.
29. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. Am J Epidemiol 1989: 129: 295-311.
30. Wahren J, Johansson B-L, Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetologia 1994; 37 (suppl 2): S99-S107.
31. Frazier WA, Hogue-Angeletti R, Bradshaw RA. Nerve growth factor and insulin, structural similarities indicate an evolutionary relationship reflected by physiological action. Science 1972; 76: 482-486.
32. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 89-94.